JP2002540769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540769A5 JP2002540769A5 JP2000601031A JP2000601031A JP2002540769A5 JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5 JP 2000601031 A JP2000601031 A JP 2000601031A JP 2000601031 A JP2000601031 A JP 2000601031A JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- substantially purified
- purified protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12210499P | 1999-02-26 | 1999-02-26 | |
| US60/122,104 | 1999-02-26 | ||
| PCT/US2000/004613 WO2000050453A1 (en) | 1999-02-26 | 2000-02-24 | A novel inhibitor of programmed cell death |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540769A JP2002540769A (ja) | 2002-12-03 |
| JP2002540769A5 true JP2002540769A5 (https=) | 2007-04-26 |
Family
ID=22400634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000601031A Abandoned JP2002540769A (ja) | 1999-02-26 | 2000-02-24 | プログラム細胞死の新規抑制剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6570002B1 (https=) |
| EP (1) | EP1161444A4 (https=) |
| JP (1) | JP2002540769A (https=) |
| AU (1) | AU760466B2 (https=) |
| CA (1) | CA2363621A1 (https=) |
| MX (1) | MXPA01008626A (https=) |
| WO (1) | WO2000050453A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030215445A1 (en) | 1997-05-23 | 2003-11-20 | Ginette Serrero | Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| US20100111928A1 (en) * | 1997-05-23 | 2010-05-06 | A & G Pharmaceutical, Inc. | Methods and kits for diagnosis tumorgenicity |
| EP1414948B1 (en) | 2001-07-10 | 2009-09-16 | Biogen Idec Inc. | Inhibition of apoptosis process and improvement of cell performance |
| US7411045B2 (en) * | 2002-11-19 | 2008-08-12 | A&G Pharmaceutical, Inc. | Autocrine growth factor receptor antibodies and methods |
| AU2003901010A0 (en) * | 2003-03-06 | 2003-03-20 | Flinders Technologies Pty Ltd | Apoptosis regulator |
| KR20060070491A (ko) * | 2003-06-23 | 2006-06-23 | 에이 앤드 지 파마슈티컬즈, 인코포레이티드 | 항종양 요법에 대한 종양 세포의 감수성 회복 및 세포 사멸유도를 위한 조성물 및 방법 |
| JP2007517763A (ja) * | 2003-08-01 | 2007-07-05 | エイアンドジー ファーマスーティカル インコーポレイテッド | Her2アンタゴニストを用いた治療への感受性を回復させる組成物および方法 |
| CN104324029A (zh) * | 2004-03-15 | 2015-02-04 | 逊尼希思制药公司 | Sns-595及其使用方法 |
| US8580814B2 (en) * | 2006-04-03 | 2013-11-12 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| CN101505753B (zh) | 2006-06-12 | 2014-05-21 | 逊尼希思制药公司 | 治疗癌症的化合物和组合物 |
| US20080063642A1 (en) * | 2006-08-02 | 2008-03-13 | Adelman Daniel C | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders |
| CN103720701A (zh) * | 2007-10-22 | 2014-04-16 | 逊尼希思制药公司 | 在联合治疗中使用(+)-1,4-二氢-7-[(3s,4s)-3-甲氧基-4-(甲氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸的方法 |
| US10975051B2 (en) | 2015-08-12 | 2021-04-13 | Memorial Sloan Kettering Cancer Center | Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
| US5646008A (en) | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
| US5622852A (en) | 1994-10-31 | 1997-04-22 | Washington University | Bcl-x/Bcl-2 associated cell death regulator |
| US5539094A (en) | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
| FI962247A7 (fi) | 1993-11-30 | 1996-07-22 | Lxr Biotechnology Inc | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät |
| US5858678A (en) | 1994-08-02 | 1999-01-12 | St. Louis University | Apoptosis-regulating proteins |
| US5858715A (en) | 1997-01-29 | 1999-01-12 | Incyte Pharmaceuticals, Inc. | Human apoptosis-associated protein |
-
2000
- 2000-02-24 CA CA002363621A patent/CA2363621A1/en not_active Abandoned
- 2000-02-24 MX MXPA01008626A patent/MXPA01008626A/es unknown
- 2000-02-24 EP EP00911926A patent/EP1161444A4/en not_active Withdrawn
- 2000-02-24 JP JP2000601031A patent/JP2002540769A/ja not_active Abandoned
- 2000-02-24 US US09/512,346 patent/US6570002B1/en not_active Expired - Lifetime
- 2000-02-24 WO PCT/US2000/004613 patent/WO2000050453A1/en not_active Ceased
- 2000-02-24 AU AU33740/00A patent/AU760466B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002519061A5 (https=) | ||
| JP2006516098A5 (https=) | ||
| JP2002540769A5 (https=) | ||
| JP2002524024A5 (https=) | ||
| JPH1072351A5 (https=) | ||
| WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
| JP2003525623A5 (https=) | ||
| JP2004532624A5 (https=) | ||
| JP2004530635A5 (https=) | ||
| JP2004508843A5 (https=) | ||
| CA2361987A1 (en) | Goodpasture antigen binding protein | |
| ATE370160T1 (de) | Peptide mit affinität zu gp120, und ihre verwendungen | |
| AU2002211115A1 (en) | Process for recovering proteins from whey protein containing feedstocks | |
| WO2001053347A3 (fr) | Gene nphs2 implique dans le syndrome nephrotique cortico-resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques | |
| JP2006510360A5 (https=) | ||
| ATE353913T1 (de) | Neue collectine | |
| AU2003264535A1 (en) | Tumor antigen protein and utilization thereof | |
| JP2001078180A5 (https=) | ||
| GB0115428D0 (en) | Antibodies, peptides, analogs and uses thereof | |
| JPH1132773A5 (https=) | ||
| CA2244928A1 (en) | Dna coding for serine/threonine kinase | |
| HK1043155A1 (zh) | 噬菌體t4基因35的基因及蛋白質排列 | |
| WO2000042063A3 (de) | Peptide zur inhibierung von hbv-core-proteinen | |
| WO2001094417A3 (en) | Novel human seven transmembrane proteins and polynucleotides encoding the same | |
| WO2001072842A3 (en) | Human 7-transmembrane proteins and polynucleotides encoding the same |